A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
| dc.contributor.author | Mastall, Maximilian | |
| dc.contributor.author | Roth, Patrick | |
| dc.contributor.author | Bink, Andrea | |
| dc.contributor.author | Fischer Maranta, Angela | |
| dc.contributor.author | Läubli, Heinz | |
| dc.contributor.author | Hottinger, Andreas Felix | |
| dc.contributor.author | Hundsberger, Thomas | |
| dc.contributor.author | Migliorini, Denis | |
| dc.contributor.author | Ochsenbein, Adrian | |
| dc.contributor.author | Seystahl, Katharina | |
| dc.contributor.author | Imbach, Lukas | |
| dc.contributor.author | Hortobágyi, Tibor | |
| dc.contributor.author | Held, Leonhard | |
| dc.contributor.author | Weller, Michael | |
| dc.contributor.author | Wirsching, Hans-Georg | |
| dc.date.accessioned | 2025-04-07T13:13:33Z | |
| dc.date.available | 2025-04-07T13:13:33Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2025-04-23 | |
| dc.date.pasync | 2025-04-23T23:08:34Z | |
| dc.date.updated | 2025-04-07T13:13:33Z | |
| dc.description.corrector | kzs | |
| dc.identifier.citation | Bmc Cancer. -24 : 1 (2024), p. 1-7. -(cikkazonosító)82. -BMC Cancer. - 1471-2407. - 1471-2407 | |
| dc.identifier.doi | http://dx.doi.org/10.1186/s12885-023-11797-z | |
| dc.identifier.issn | 1471-2407 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM129344 | |
| dc.identifier.scopus | 85182461604 | |
| dc.identifier.uri | https://hdl.handle.net/2437/388925 | |
| dc.identifier.url | https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11797-z | |
| dc.identifier.wos | 001143873900006 | |
| dc.language | und | |
| dc.rights.access | open access journal | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_Mastall et al_BMC Cancer_2024.pdf
- Méret:
- 932.32 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat